New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. DPZ
6. PRIM
7. META
8. SPY
9. MTB
10. NAVN

Go back to New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 1.31 +0.01 (0.77%)
Previous Close $1.30    52 Week High $10.16 
Open $1.29    52 Week Low $2.91 
Day High $1.32    P/E N/A 
Day Low $1.27    EPS $-0.41 
Volume 27,395